We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+19.39%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$875B
AUM Growth
+$257B
Cap. Flow
+$13B
Cap. Flow %
1.48%
Top 10 Hldgs %
22.67%
Holding
15,445
New
2,573
Increased
6,088
Reduced
4,803
Closed
1,873

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.91B
2
SPCX
SpaceX
SPCX
+$871M
3
LLY icon
Eli Lilly
LLY
+$719M
4
AMZN icon
Amazon
AMZN
+$698M
5
NFLX icon
Netflix
NFLX
+$627M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.67%
2 Technology 3.92%
3 Healthcare 2.55%
4 Industrials 2.24%
5 Financials 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OII icon
9001
PUT
Oceaneering
OII
$4.63B
$705K ﹤0.01%
17,400
+10,900
+168% +$411K
TIER
9002
T. Rowe Price International Equity Research ETF
TIER
$140M
$705K ﹤0.01%
21,773
-2,718
-11% -$85K
RDZN icon
9003
Roadzen
RDZN
$97.9M
$705K ﹤0.01%
+482,850
New +$766K
DORM icon
9004
Dorman Products
DORM
$3.76B
$704K ﹤0.01%
5,162
-83,673
-94% -$9.91M
ACOG
9005
Alpha Cognition
ACOG
$190M
$704K ﹤0.01%
97,546
+7,957
+9% +$49.8K
TREE icon
9006
PUT
LendingTree
TREE
$390M
$704K ﹤0.01%
15,900
-6,900
-30% -$279K
DBRG icon
9007
PUT
DigitalBridge
DBRG
$2.98B
$704K ﹤0.01%
44,600
-15,200
-25% -$238K
PBT
9008
CALL
Permian Basin Royalty Trust
PBT
$1.66B
$704K ﹤0.01%
28,100
+9,300
+49% +$235K
CGON icon
9009
PUT
CG Oncology
CGON
$6.54B
$703K ﹤0.01%
9,900
-26,800
-73% -$1.75M
VEGI icon
9010
iShares MSCI Agriculture Producers ETF
VEGI
$172M
$703K ﹤0.01%
15,944
-181,555
-92% -$8.13M
LRGG
9011
Nomura Focused Large Growth ETF
LRGG
$290M
$703K ﹤0.01%
25,582
+6,788
+36% +$187K
WW
9012
CALL
WW International
WW
$152M
$703K ﹤0.01%
44,000
+7,600
+21% +$101K
SXT icon
9013
CALL
Sensient Technologies
SXT
$5.39B
$703K ﹤0.01%
5,700
-6,400
-53% -$712K
AESI icon
9014
PUT
Atlas Energy Solutions
AESI
$1.64B
$703K ﹤0.01%
42,300
+26,700
+171% +$437K
MYCG
9015
State Street My2027 Corporate Bond ETF
MYCG
$43.6M
$702K ﹤0.01%
28,110
+14,189
+102% +$354K
EZA icon
9016
PUT
iShares MSCI South Africa ETF
EZA
$562M
$701K ﹤0.01%
11,100
+3,900
+54% +$267K
DYNB
9017
Hartford Dynamic Bond ETF
DYNB
$63.2M
$701K ﹤0.01%
17,851
-22,775
-56% -$897K
SYRE icon
9018
PUT
Spyre Therapeutics
SYRE
$8.01B
$701K ﹤0.01%
7,900
-7,400
-48% -$540K
INTA icon
9019
PUT
Intapp
INTA
$2.91B
$701K ﹤0.01%
27,800
+8,200
+42% +$187K
EWK icon
9020
iShares MSCI Belgium ETF
EWK
$166M
$700K ﹤0.01%
25,867
-39,514
-60% -$1.04M
ITDI icon
9021
iShares LifePath Target Date 2065 ETF
ITDI
$29M
$700K ﹤0.01%
16,599
+6,295
+61% +$257K
VUSG
9022
Vanguard Wellington U.S. Growth Active ETF
VUSG
$32.9M
$699K ﹤0.01%
10,851
+5,113
+89% +$321K
AMZZ icon
9023
PUT
GraniteShares 2x Long AMZN Daily ETF
AMZZ
$37.9M
$699K ﹤0.01%
22,700
-9,500
-30% -$333K
ABEO icon
9024
CALL
Abeona Therapeutics
ABEO
$311M
$699K ﹤0.01%
113,100
-92,100
-45% -$506K
RMHY
9025
Global X Adaptive Risk Managed Yield ETF
RMHY
$49.1M
$699K ﹤0.01%
+27,936
New +$698K

Similar funds

Citadel Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.

  • Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
  • Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
  • Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
  • Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
  • Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
  • Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.